| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 2.86e-12 | 431 | 140 | 21 | GO:0004984 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | KCNH8 SLC22A23 CFTR PKD1L1 MFSD2B SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 PANX1 KCNK16 TMC4 CALHM6 ABCA10 ABCC6 SLC1A7 SLC22A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 PIEZO2 ATP8A1 SLC16A4 ABCA6 ABCA5 SLC18A2 KCNK2 HTR3D SLC26A11 CNGA1 SLC38A6 | 5.12e-12 | 1180 | 140 | 33 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | KCNH8 SLC22A23 CFTR PKD1L1 MFSD2B SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 PANX1 KCNK16 TMC4 CALHM6 ABCA10 ABCC6 SLC1A7 SLC22A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 PIEZO2 ATP8A1 SLC16A4 ABCA6 ABCA5 SLC18A2 KCNK2 HTR3D SLC26A11 CNGA1 SLC38A6 | 5.39e-11 | 1289 | 140 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | CFTR MFSD2B SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 ABCA10 ABCC6 SLC1A7 SLC22A7 SLC6A1 SLC5A11 MFSD2A SLC46A3 ATP8A1 SLC16A4 ABCA6 ABCA5 SLC18A2 SLC26A11 | 1.45e-10 | 477 | 140 | 20 | GO:0022804 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 GPR160 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 4.68e-10 | 884 | 140 | 26 | GO:0004930 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | KCNH8 CFTR PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 TMC4 CALHM6 SLC1A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 PIEZO2 ATP8A1 SLC18A2 KCNK2 HTR3D SLC26A11 CNGA1 | 3.43e-08 | 793 | 140 | 22 | GO:0015075 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | MFSD2B SLCO4A1 SLC38A5 SLCO3A1 SLC1A7 SLC22A7 SLC6A1 SLC5A11 MFSD2A SLC46A3 SLC16A4 SLC18A2 SLC26A11 | 1.71e-07 | 296 | 140 | 13 | GO:0015291 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 GPR160 OR10G7 OR51S1 CD247 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 HTR3D ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 1.93e-07 | 1353 | 140 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNH8 PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 CALHM6 SLC1A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 PIEZO2 ATP8A1 SLC18A2 KCNK2 HTR3D CNGA1 | 2.02e-07 | 664 | 140 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | CFTR SLCO4A1 SLC38A5 SLCO3A1 PANX1 SLC1A7 SLC22A7 SLC6A1 MFSD2A SLC16A4 SLC26A11 SLC38A6 | 1.09e-06 | 293 | 140 | 12 | GO:0008514 |
| GeneOntologyMolecularFunction | odorant binding | 3.17e-06 | 127 | 140 | 8 | GO:0005549 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | KCNH8 CFTR PKD1L1 PANX1 KCNK16 TMC4 CALHM6 SLC1A7 RYR2 PIEZO2 KCNK2 HTR3D SLC26A11 CNGA1 | 4.39e-06 | 459 | 140 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNH8 PKD1L1 SLC38A5 PANX1 KCNK16 SLC1A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 SLC18A2 KCNK2 CNGA1 | 5.09e-06 | 465 | 140 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | KCNH8 CFTR PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 ABCC6 SLC1A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 SLC18A2 KCNK2 SLC26A11 CNGA1 | 6.08e-06 | 758 | 140 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | lipid transporter activity | MFSD2B SLCO4A1 SLCO3A1 ABCA10 SLC22A7 MFSD2A ATP8A1 ABCA6 ABCA5 | 1.02e-05 | 196 | 140 | 9 | GO:0005319 |
| GeneOntologyMolecularFunction | symporter activity | 1.09e-05 | 150 | 140 | 8 | GO:0015293 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.18e-05 | 109 | 140 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | channel activity | KCNH8 CFTR PKD1L1 PANX1 KCNK16 TMC4 CALHM6 SLC1A7 RYR2 PIEZO2 KCNK2 HTR3D SLC26A11 CNGA1 | 1.99e-05 | 525 | 140 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | KCNH8 CFTR PKD1L1 PANX1 KCNK16 TMC4 CALHM6 SLC1A7 RYR2 PIEZO2 KCNK2 HTR3D SLC26A11 CNGA1 | 2.04e-05 | 526 | 140 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.35e-05 | 49 | 140 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | KCNH8 PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 SLC1A7 RYR2 SLC6A1 SLC5A11 MFSD2A SLC46A3 SLC18A2 KCNK2 CNGA1 | 3.51e-05 | 627 | 140 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.16e-04 | 14 | 140 | 3 | GO:0015132 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.26e-04 | 334 | 140 | 10 | GO:0022836 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.44e-04 | 15 | 140 | 3 | GO:0071714 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | KCNH8 PKD1L1 PANX1 KCNK16 CALHM6 RYR2 PIEZO2 KCNK2 HTR3D CNGA1 | 1.56e-04 | 343 | 140 | 10 | GO:0005261 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.06e-04 | 171 | 140 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 2.55e-04 | 18 | 140 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.63e-04 | 81 | 140 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.64e-04 | 178 | 140 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC38A5 TCIRG1 SLC1A7 SLC6A1 SLC5A11 MFSD2A ATP8A1 SLC18A2 SLC26A11 | 2.78e-04 | 301 | 140 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 2.90e-04 | 4 | 140 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 3.01e-04 | 19 | 140 | 3 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 3.01e-04 | 19 | 140 | 3 | GO:0022840 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO9B CFTR TCIRG1 ARID1A ABCA10 ABCC6 MFSD2A ATP8A1 ABCA6 ABCA5 YME1L1 TOP2A TOP2B | 3.91e-04 | 614 | 140 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 6.53e-04 | 207 | 140 | 7 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 6.71e-04 | 208 | 140 | 7 | GO:0005342 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 6.91e-04 | 151 | 140 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.32e-03 | 171 | 140 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 1.33e-03 | 8 | 140 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.52e-03 | 119 | 140 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.58e-03 | 33 | 140 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 1.70e-03 | 9 | 140 | 2 | GO:0015186 | |
| GeneOntologyMolecularFunction | snoRNA binding | 1.72e-03 | 34 | 140 | 3 | GO:0030515 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.73e-03 | 73 | 140 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.89e-03 | 125 | 140 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.12e-03 | 10 | 140 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.96e-03 | 41 | 140 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | Roundabout binding | 3.08e-03 | 12 | 140 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | serotonin binding | 3.62e-03 | 13 | 140 | 2 | GO:0051378 | |
| GeneOntologyMolecularFunction | GTPase inhibitor activity | 3.62e-03 | 13 | 140 | 2 | GO:0005095 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water | 3.62e-03 | 13 | 140 | 2 | GO:0016717 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.20e-03 | 14 | 140 | 2 | GO:0140333 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 BBS1 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 7.85e-13 | 465 | 140 | 22 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.63e-12 | 432 | 140 | 21 | GO:0050911 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 RYR2 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 8.29e-12 | 524 | 140 | 22 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.46e-11 | 485 | 140 | 21 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 BBS1 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.91e-11 | 547 | 140 | 22 | GO:0007606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 PIEZO2 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 6.31e-11 | 582 | 140 | 22 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 PKD1L1 OR2C3 OR6K6 RYR2 OR10G7 OR51S1 PIEZO2 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.09e-10 | 722 | 140 | 24 | GO:0051606 |
| GeneOntologyBiologicalProcess | sensory perception | OR5M10 OR8D1 OR10H5 EYA4 OR5M1 OR9K2 WFS1 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 BBS1 ABCC6 OR6K6 OR10G7 OR51S1 PIEZO2 HMCN1 OR10A4 OTOF OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 CNGA1 | 1.32e-10 | 1072 | 140 | 29 | GO:0007600 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 IQGAP2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 MFSD2B OR6K6 GPR160 OR10G7 SLIT2 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 KCNK2 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 PIK3R5 PMCHL2 | 7.95e-10 | 1395 | 140 | 32 | GO:0007186 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | KCNH8 WFS1 SLC22A23 CFTR PKD1L1 SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 PANX1 KCNK16 TMC4 CALHM6 ABCC6 SLC1A7 SLC22A7 RYR2 SLC6A1 SLC5A11 SLC46A3 PIEZO2 ATP8A1 MTOR SLC18A2 AGTR1 KCNK2 HTR3D SLC26A11 CNGA1 | 3.66e-08 | 1374 | 140 | 29 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | KCNH8 CFTR PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 TMC4 CALHM6 ABCC6 SLC1A7 RYR2 SLC6A1 SLC46A3 PIEZO2 ATP8A1 MTOR SLC18A2 AGTR1 KCNK2 HTR3D SLC26A11 CNGA1 | 1.74e-06 | 1115 | 140 | 23 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 4.57e-05 | 2 | 140 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | organic anion transport | CFTR SLCO4A1 SLC38A5 SLCO3A1 PANX1 ABCC6 SLC1A7 SLC22A7 SLC6A1 MFSD2A SLC16A4 SLC26A11 SLC38A6 | 5.05e-05 | 515 | 140 | 13 | GO:0015711 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.49e-05 | 153 | 140 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLCO4A1 SLC38A5 SLCO3A1 ABCC6 SLC1A7 SLC22A7 SLC6A1 MFSD2A SLC16A4 SLC26A11 SLC38A6 | 1.15e-04 | 410 | 140 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | SLCO4A1 SLC38A5 SLCO3A1 ABCC6 SLC1A7 SLC22A7 SLC6A1 MFSD2A SLC16A4 SLC26A11 SLC38A6 | 1.20e-04 | 412 | 140 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | CFTR SLC38A5 SLCO3A1 BCR PTGS1 SLC6A1 SLIT2 MFSD2A ATP8A1 AGTR1 | 1.23e-04 | 344 | 140 | 10 | GO:0003018 |
| GeneOntologyBiologicalProcess | lipid localization | CFTR MFSD2B SLCO4A1 SLCO3A1 ABCA10 SLC22A7 MFSD2A ATP8A1 ABCA6 ABCA5 LPCAT3 AGTR1 FBXW7 | 1.28e-04 | 565 | 140 | 13 | GO:0010876 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | WFS1 UGGT1 CFTR PANX1 CASTOR2 ADTRP ERBIN SERPINA12 RYR2 SLC6A1 SLIT2 DUOX1 PPP5C MTOR SLC18A2 RPTOR AGTR1 HTR3D PRKDC EIF2AK3 TOP2B | 1.36e-04 | 1272 | 140 | 21 | GO:1901698 |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell migration | 1.39e-04 | 39 | 140 | 4 | GO:0071676 | |
| GeneOntologyBiologicalProcess | lipid transport | CFTR MFSD2B SLCO4A1 SLCO3A1 ABCA10 SLC22A7 MFSD2A ATP8A1 ABCA6 ABCA5 LPCAT3 AGTR1 | 1.77e-04 | 506 | 140 | 12 | GO:0006869 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | KCNH8 CFTR PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 SLC1A7 RYR2 SLC6A1 SLC46A3 MTOR SLC18A2 AGTR1 KCNK2 HTR3D SLC26A11 CNGA1 | 1.84e-04 | 1017 | 140 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | KCNH8 CFTR PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 CALHM6 RYR2 SLC6A1 SLC46A3 PIEZO2 ATP8A1 SLC18A2 AGTR1 KCNK2 CNGA1 | 2.24e-04 | 942 | 140 | 17 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 2.57e-04 | 183 | 140 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | regulation of inorganic anion transmembrane transport | 2.72e-04 | 4 | 140 | 2 | GO:1903795 | |
| GeneOntologyBiologicalProcess | positive regulation of pentose-phosphate shunt | 2.72e-04 | 4 | 140 | 2 | GO:1905857 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | KCNH8 WFS1 CFTR PKD1L1 SLC38A5 TCIRG1 PANX1 KCNK16 CALHM6 RYR2 SLC6A1 SLC5A11 SLC46A3 PIEZO2 ATP8A1 SLC18A2 AGTR1 KCNK2 CNGA1 | 3.12e-04 | 1157 | 140 | 19 | GO:0006812 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 3.17e-04 | 87 | 140 | 5 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 3.34e-04 | 88 | 140 | 5 | GO:0010232 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | WFS1 CFTR PANX1 LBR TM6SF2 PTGS1 ABCC6 OR6K6 RYR2 MFSD2A FADS1 BCAP29 OR10A4 OTOF MTOR LPCAT3 SEC11A KCNK2 UGT2B4 DEGS2 TRAM2 EIF2AK3 | 6.09e-05 | 1293 | 142 | 22 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | WFS1 CFTR PANX1 LBR TM6SF2 PTGS1 ABCC6 OR6K6 RYR2 MFSD2A FADS1 BCAP29 OR10A4 OTOF MTOR LPCAT3 SEC11A KCNK2 UGT2B4 DEGS2 TRAM2 EIF2AK3 | 6.52e-05 | 1299 | 142 | 22 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | WFS1 CFTR PANX1 LBR TM6SF2 PTGS1 ABCC6 OR6K6 RYR2 MFSD2A FADS1 BCAP29 OR10A4 OTOF MTOR LPCAT3 SEC11A KCNK2 UGT2B4 DEGS2 TRAM2 EIF2AK3 | 8.91e-05 | 1327 | 142 | 22 | GO:0042175 |
| GeneOntologyCellularComponent | basolateral plasma membrane | CFTR SLCO4A1 SLCO3A1 ERBIN ABCC6 SLC22A7 OTOF AGTR1 SLC26A11 | 3.47e-04 | 320 | 142 | 9 | GO:0016323 |
| GeneOntologyCellularComponent | TORC1 complex | 6.75e-04 | 6 | 142 | 2 | GO:0031931 | |
| GeneOntologyCellularComponent | basal plasma membrane | CFTR SLCO4A1 SLCO3A1 ERBIN ABCC6 SLC22A7 OTOF AGTR1 SLC26A11 | 7.18e-04 | 354 | 142 | 9 | GO:0009925 |
| Domain | Olfact_rcpt | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 2.62e-12 | 393 | 143 | 21 | IPR000725 |
| Domain | GPCR_Rhodpsn_7TM | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 GPR160 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 7.61e-12 | 670 | 143 | 26 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 GPR160 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 1.25e-11 | 685 | 143 | 26 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 GPR160 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 1.51e-11 | 691 | 143 | 26 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 GPR160 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 1.56e-11 | 692 | 143 | 26 | IPR000276 |
| Domain | 7tm_1 | OR5M10 OR8D1 OR10H5 HTR1E HTR1F OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 AGTR1 OR52N4 ACKR2 OR8G5 OR10G9 OR10G8 OR6C6 | 5.85e-11 | 677 | 143 | 25 | PF00001 |
| Domain | MFS_dom | SLC22A23 MFSD2B SLCO4A1 SLCO3A1 SLC22A7 MFSD2A SLC46A3 SLC16A4 SLC18A2 | 9.10e-07 | 134 | 143 | 9 | IPR020846 |
| Domain | MFS | SLC22A23 MFSD2B SLCO4A1 SLC22A7 MFSD2A SLC46A3 SLC16A4 SLC18A2 | 1.79e-06 | 108 | 143 | 8 | PS50850 |
| Domain | ABC_tran | 3.22e-05 | 48 | 143 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.22e-05 | 48 | 143 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.57e-05 | 49 | 143 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 3.94e-05 | 50 | 143 | 5 | IPR003439 | |
| Domain | - | 5.82e-05 | 2 | 143 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 5.82e-05 | 2 | 143 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 5.82e-05 | 2 | 143 | 2 | PF00204 | |
| Domain | - | 5.82e-05 | 2 | 143 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 5.82e-05 | 2 | 143 | 2 | IPR018522 | |
| Domain | Topo_IIA | 5.82e-05 | 2 | 143 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 5.82e-05 | 2 | 143 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 5.82e-05 | 2 | 143 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 5.82e-05 | 2 | 143 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 5.82e-05 | 2 | 143 | 2 | IPR013759 | |
| Domain | TOP4c | 5.82e-05 | 2 | 143 | 2 | SM00434 | |
| Domain | TOP2c | 5.82e-05 | 2 | 143 | 2 | SM00433 | |
| Domain | 5HT1F_rcpt | 5.82e-05 | 2 | 143 | 2 | IPR000450 | |
| Domain | Topo_IIA-like_dom | 5.82e-05 | 2 | 143 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 5.82e-05 | 2 | 143 | 2 | IPR013506 | |
| Domain | DTHCT | 5.82e-05 | 2 | 143 | 2 | PF08070 | |
| Domain | - | 5.82e-05 | 2 | 143 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 5.82e-05 | 2 | 143 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 5.82e-05 | 2 | 143 | 2 | PF16898 | |
| Domain | Topo_IIA_A/C | 5.82e-05 | 2 | 143 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 5.82e-05 | 2 | 143 | 2 | PS00177 | |
| Domain | ABC_A | 9.19e-05 | 12 | 143 | 3 | IPR026082 | |
| Domain | Arg_repress_C-like | 1.74e-04 | 3 | 143 | 2 | IPR024946 | |
| Domain | Prepro-melanin_conc_hormone | 1.74e-04 | 3 | 143 | 2 | IPR005456 | |
| Domain | Pro-MCH | 1.74e-04 | 3 | 143 | 2 | PF05824 | |
| Domain | - | 1.74e-04 | 3 | 143 | 2 | 3.30.1360.40 | |
| Domain | ARM-like | 2.38e-04 | 270 | 143 | 9 | IPR011989 | |
| Domain | ARM-type_fold | DOCK11 HUWE1 ARID1A MTOR RPTOR MROH2B ANKAR PRKDC AGBL1 TANGO6 | 2.88e-04 | 339 | 143 | 10 | IPR016024 |
| Domain | ABC_transporter_CS | 2.94e-04 | 42 | 143 | 4 | IPR017871 | |
| Domain | MFS_1 | 3.11e-04 | 77 | 143 | 5 | PF07690 | |
| Domain | MFS | 3.11e-04 | 77 | 143 | 5 | IPR011701 | |
| Domain | Toprim | 3.46e-04 | 4 | 143 | 2 | PF01751 | |
| Domain | Toprim_domain | 3.46e-04 | 4 | 143 | 2 | IPR006171 | |
| Domain | TOPRIM | 3.46e-04 | 4 | 143 | 2 | PS50880 | |
| Domain | - | 5.28e-04 | 21 | 143 | 3 | 3.30.230.10 | |
| Domain | FATC | 5.73e-04 | 5 | 143 | 2 | PF02260 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 6.08e-04 | 22 | 143 | 3 | IPR014721 | |
| Domain | AAA | 8.51e-04 | 144 | 143 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 8.51e-04 | 144 | 143 | 6 | IPR003593 | |
| Domain | FAT | 8.56e-04 | 6 | 143 | 2 | PS51189 | |
| Domain | FATC | 8.56e-04 | 6 | 143 | 2 | PS51190 | |
| Domain | FAT | 8.56e-04 | 6 | 143 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 8.56e-04 | 6 | 143 | 2 | IPR003151 | |
| Domain | FATC_dom | 8.56e-04 | 6 | 143 | 2 | IPR003152 | |
| Domain | PIK_FAT | 8.56e-04 | 6 | 143 | 2 | IPR014009 | |
| Domain | FATC | 8.56e-04 | 6 | 143 | 2 | SM01343 | |
| Domain | CXCR4/ACKR2 | 1.19e-03 | 7 | 143 | 2 | IPR001277 | |
| Domain | FA_desaturase_dom | 1.58e-03 | 8 | 143 | 2 | IPR005804 | |
| Domain | FA_desaturase | 1.58e-03 | 8 | 143 | 2 | PF00487 | |
| Domain | - | 1.63e-03 | 222 | 143 | 7 | 1.25.10.10 | |
| Domain | 5HT_rcpt | 2.02e-03 | 9 | 143 | 2 | IPR002231 | |
| Domain | HEAT_REPEAT | 2.04e-03 | 70 | 143 | 4 | PS50077 | |
| Domain | Ribosomal_S5_D2-typ_fold | 2.21e-03 | 34 | 143 | 3 | IPR020568 | |
| Domain | An_peroxidase | 2.52e-03 | 10 | 143 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.52e-03 | 10 | 143 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 2.52e-03 | 10 | 143 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 2.52e-03 | 10 | 143 | 2 | PS50292 | |
| Domain | - | 2.52e-03 | 10 | 143 | 2 | 1.10.640.10 | |
| Domain | OA_transporter | 3.65e-03 | 12 | 143 | 2 | IPR004156 | |
| Domain | OATP | 3.65e-03 | 12 | 143 | 2 | PF03137 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 4.99e-03 | 14 | 143 | 2 | IPR003938 | |
| Domain | 2pore_dom_K_chnl | 5.73e-03 | 15 | 143 | 2 | IPR003280 | |
| Domain | PI3/4_kinase_CS | 5.73e-03 | 15 | 143 | 2 | IPR018936 | |
| Domain | - | 6.51e-03 | 16 | 143 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 6.51e-03 | 16 | 143 | 2 | SM00146 | |
| Domain | Aa_trans | 7.34e-03 | 17 | 143 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 7.34e-03 | 17 | 143 | 2 | IPR013057 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 2.10e-12 | 389 | 110 | 21 | M14091 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 7.90e-12 | 417 | 110 | 21 | M4072 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OTOF OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 CNGA1 | 5.46e-10 | 636 | 110 | 23 | M41834 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR8D1 OR10H5 OR5D14 OR13C3 OR10G7 OR10H2 OR10H1 OR10G9 OR10G8 | 3.37e-09 | 70 | 110 | 9 | MM14984 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR8D1 OR10H5 OR5D14 OR13C3 OR10G7 OR10H2 OR10H1 OR10G9 OR10G8 CNGA1 | 2.28e-06 | 190 | 110 | 10 | MM15687 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CFTR RAB11FIP2 SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 ABCA10 ABCC6 SLC1A7 SLC22A7 RYR2 SLC6A1 SLC5A11 ATP8A1 ABCA6 ABCA5 SLC18A2 SLC26A11 YME1L1 | 3.74e-06 | 736 | 110 | 19 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CFTR RAB11FIP2 SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 ABCC6 SLC1A7 SLC22A7 RYR2 SLC6A1 SLC5A11 ATP8A1 ABCA6 ABCA5 SLC18A2 SLC26A11 YME1L1 | 5.03e-06 | 681 | 110 | 18 | MM14985 |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.25e-05 | 44 | 110 | 5 | M11911 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO4A1 SLC38A5 SLCO3A1 SLC1A7 SLC22A7 SLC6A1 SLC5A11 SLC18A2 SLC26A11 | 1.01e-04 | 238 | 110 | 9 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLCO4A1 SLC38A5 SLCO3A1 SLC1A7 SLC22A7 SLC6A1 SLC5A11 SLC18A2 SLC26A11 | 1.43e-04 | 249 | 110 | 9 | M5988 |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 3.46e-04 | 18 | 110 | 3 | M524 | |
| Pathway | WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE | 4.83e-04 | 47 | 110 | 4 | M39518 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 6.61e-04 | 51 | 110 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 6.61e-04 | 51 | 110 | 4 | MM14499 | |
| Pubmed | OR5M10 OR8D1 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 8.87e-14 | 343 | 144 | 17 | 32295537 | |
| Pubmed | OR5M10 OR8D1 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.02e-13 | 346 | 144 | 17 | 14611657 | |
| Pubmed | OR5M10 OR8D1 OR10H5 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR13C4 OR2C3 OR6K6 OR10G7 OR51S1 OR10A4 OR10H2 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 | 1.24e-13 | 541 | 144 | 20 | 14983052 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5M10 OR8D1 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR10G7 OR51S1 OR10A4 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.09e-12 | 340 | 144 | 16 | 11875048 |
| Pubmed | OR5M10 OR8D1 OR5M1 OR9K2 OR5D14 OR9I1 OR13C3 OR10G7 OR51S1 OR10A4 OR10H1 OR52N4 OR8G5 OR10G9 OR10G8 OR6C6 | 1.09e-12 | 340 | 144 | 16 | 11802173 | |
| Pubmed | DEFOG: a practical scheme for deciphering families of genes. | 3.60e-07 | 219 | 144 | 9 | 12213199 | |
| Pubmed | 1.38e-06 | 6 | 144 | 3 | 30865892 | ||
| Pubmed | 1.95e-06 | 22 | 144 | 4 | 8894702 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 2.98e-06 | 211 | 144 | 8 | 17314511 | |
| Pubmed | The human ATP-binding cassette (ABC) transporter superfamily. | 8.17e-06 | 10 | 144 | 3 | 11435397 | |
| Pubmed | 8.17e-06 | 10 | 144 | 3 | 31210753 | ||
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.12e-05 | 11 | 144 | 3 | 20427287 | |
| Pubmed | 1.12e-05 | 11 | 144 | 3 | 17903301 | ||
| Pubmed | 1.68e-05 | 193 | 144 | 7 | 19343046 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 24048577 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30202948 | ||
| Pubmed | Dual TORK/DNA-PK inhibition blocks critical signaling pathways in chronic lymphocytic leukemia. | 1.70e-05 | 2 | 144 | 2 | 27235137 | |
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 1.70e-05 | 2 | 144 | 2 | 19222228 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 29500156 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 2555055 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 1331984 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31106979 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16091284 | ||
| Pubmed | Protein phosphatase 5 regulates the function of 53BP1 after neocarzinostatin-induced DNA damage. | 1.70e-05 | 2 | 144 | 2 | 19176521 | |
| Pubmed | Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. | 1.70e-05 | 2 | 144 | 2 | 23160380 | |
| Pubmed | Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. | 1.70e-05 | 2 | 144 | 2 | 1608964 | |
| Pubmed | Effect of DNA methylation profile on OATP3A1 and OATP4A1 transcript levels in colorectal cancer. | 1.70e-05 | 2 | 144 | 2 | 26349991 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 32535049 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 1380833 | ||
| Pubmed | DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer. | 1.70e-05 | 2 | 144 | 2 | 32209447 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 18270303 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 38407308 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 33826602 | ||
| Pubmed | Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. | 1.70e-05 | 2 | 144 | 2 | 23399433 | |
| Pubmed | Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells. | 1.70e-05 | 2 | 144 | 2 | 15044480 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 17526531 | ||
| Pubmed | DNA topoisomerase II distribution in mouse preimplantation embryos. | 1.70e-05 | 2 | 144 | 2 | 11835579 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 27649073 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 2556712 | ||
| Pubmed | mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors. | 1.70e-05 | 2 | 144 | 2 | 29786082 | |
| Pubmed | Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning. | 1.70e-05 | 2 | 144 | 2 | 27018708 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 10473615 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16847060 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 9224616 | ||
| Pubmed | DNA damage response during chromatin remodeling in elongating spermatids of mice. | 1.70e-05 | 2 | 144 | 2 | 18032420 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22111588 | ||
| Pubmed | Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. | 1.70e-05 | 2 | 144 | 2 | 17578914 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 21422162 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 25486193 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 1309226 | ||
| Pubmed | Kinetic analysis of human topoisomerase IIalpha and beta DNA binding by surface plasmon resonance. | 1.70e-05 | 2 | 144 | 2 | 14596941 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 17361331 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 10095062 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28423496 | ||
| Pubmed | Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. | 1.70e-05 | 2 | 144 | 2 | 14996935 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 9795238 | ||
| Pubmed | The distribution of DNA topoisomerase II isoforms in differentiated adult mouse tissues. | 1.70e-05 | 2 | 144 | 2 | 8241259 | |
| Pubmed | Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. | 1.70e-05 | 2 | 144 | 2 | 11927602 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 17182034 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 11181993 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 11070051 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28700616 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28087392 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 28472494 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 17301289 | ||
| Pubmed | Myelinating Schwann cells ensheath multiple axons in the absence of E3 ligase component Fbxw7. | 1.70e-05 | 2 | 144 | 2 | 31278268 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 32218491 | ||
| Pubmed | FBW7 Regulates the Autophagy Signal in Mesangial Cells Induced by High Glucose. | 1.70e-05 | 2 | 144 | 2 | 31119177 | |
| Pubmed | Conditional Knockout of Raptor/mTORC1 Results in Dentin Malformation. | 1.70e-05 | 2 | 144 | 2 | 30984011 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30169847 | ||
| Pubmed | Hepatic peroxisomal β-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation. | 1.70e-05 | 2 | 144 | 2 | 32687428 | |
| Pubmed | Temporal mTOR inhibition protects Fbxw7-deficient mice from radiation-induced tumor development. | 1.70e-05 | 2 | 144 | 2 | 23454868 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 9155056 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 16712776 | ||
| Pubmed | Activity-independent targeting of mTOR to lysosomes in primary osteoclasts. | 1.70e-05 | 2 | 144 | 2 | 28592812 | |
| Pubmed | Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms. | 1.70e-05 | 2 | 144 | 2 | 8710863 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 26612825 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 8299728 | ||
| Pubmed | DNA-PKcs function regulated specifically by protein phosphatase 5. | 1.70e-05 | 2 | 144 | 2 | 14734805 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 20439490 | ||
| Pubmed | 1.93e-05 | 13 | 144 | 3 | 16403838 | ||
| Pubmed | 3.05e-05 | 15 | 144 | 3 | 12393188 | ||
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 3.74e-05 | 16 | 144 | 3 | 35307651 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.67e-05 | 400 | 144 | 9 | 35013556 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 8188237 | ||
| Pubmed | FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. | 5.09e-05 | 3 | 144 | 2 | 18787170 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 23440873 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 11136718 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 26575021 | ||
| Pubmed | mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition. | 5.09e-05 | 3 | 144 | 2 | 25385646 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28813526 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28283069 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 24808172 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 17656678 | ||
| Pubmed | Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy. | 5.09e-05 | 3 | 144 | 2 | 20008564 | |
| Pubmed | Identification of functional nuclear export sequences in human topoisomerase IIalpha and beta. | 5.09e-05 | 3 | 144 | 2 | 12821127 | |
| Pubmed | Lipid signalling drives proteolytic rewiring of mitochondria by YME1L. | 5.09e-05 | 3 | 144 | 2 | 31695197 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 22356909 | ||
| Pubmed | mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation. | 5.09e-05 | 3 | 144 | 2 | 26522726 | |
| Pubmed | Leucine regulates autophagy via acetylation of the mTORC1 component raptor. | 5.09e-05 | 3 | 144 | 2 | 32561715 | |
| Cytoband | 11q24.2 | 1.72e-06 | 63 | 144 | 5 | 11q24.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q24 | 3.32e-05 | 191 | 144 | 6 | chr11q24 | |
| Cytoband | 19p13.1 | 4.71e-04 | 48 | 144 | 3 | 19p13.1 | |
| GeneFamily | Olfactory receptors, family 10 | 9.37e-08 | 66 | 103 | 7 | 157 | |
| GeneFamily | Solute carriers | SLC22A23 SLCO4A1 SLC38A5 SLCO3A1 SLC1A7 SLC22A7 SLC6A1 SLC5A11 SLC46A3 SLC16A4 SLC18A2 SLC26A11 SLC38A6 | 3.84e-07 | 395 | 103 | 13 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 6.24e-05 | 14 | 103 | 3 | 805 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 1.91e-04 | 4 | 103 | 2 | 1332 | |
| GeneFamily | Topoisomerases | 4.75e-04 | 6 | 103 | 2 | 1050 | |
| GeneFamily | Fatty acid desaturases | 8.80e-04 | 8 | 103 | 2 | 553 | |
| GeneFamily | Tudor domain containing | 1.21e-03 | 37 | 103 | 3 | 780 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 1.71e-03 | 11 | 103 | 2 | 559 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 2.41e-03 | 13 | 103 | 2 | 170 | |
| GeneFamily | ATP binding cassette subfamily C | 2.41e-03 | 13 | 103 | 2 | 807 | |
| GeneFamily | Potassium two pore domain channel subfamily K | 3.22e-03 | 15 | 103 | 2 | 277 | |
| GeneFamily | Olfactory receptors, family 9 | 7.52e-03 | 23 | 103 | 2 | 156 | |
| GeneFamily | Olfactory receptors, family 13 | 7.52e-03 | 23 | 103 | 2 | 162 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-08 | 195 | 144 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-08 | 195 | 144 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.39e-07 | 181 | 144 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-07 | 186 | 144 | 8 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-07 | 196 | 144 | 8 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-07 | 200 | 144 | 8 | 3e0041c04e42a47257517dae8707a6454570c256 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-06 | 164 | 144 | 7 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-06 | 164 | 144 | 7 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-06 | 167 | 144 | 7 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 174 | 144 | 7 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 175 | 144 | 7 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-06 | 175 | 144 | 7 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 176 | 144 | 7 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 176 | 144 | 7 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 179 | 144 | 7 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-06 | 181 | 144 | 7 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 185 | 144 | 7 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 186 | 144 | 7 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-06 | 188 | 144 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 189 | 144 | 7 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.89e-06 | 190 | 144 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-06 | 192 | 144 | 7 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 192 | 144 | 7 | 9ae05db5bfb8b9d3935c0328e6f2d489d2b1ebfd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.10e-06 | 192 | 144 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 192 | 144 | 7 | a116db7dec495e5a0ba9c7537057cd1e567d7885 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-06 | 192 | 144 | 7 | 66defad13bd8e79319741e43ddb056841710b1d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-06 | 124 | 144 | 6 | 1fec6663cea40017438ead397b3bf8b3cdb67e58 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.43e-06 | 195 | 144 | 7 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-06 | 196 | 144 | 7 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-06 | 196 | 144 | 7 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.55e-06 | 196 | 144 | 7 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.67e-06 | 197 | 144 | 7 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|normal_Lung / Location, Cell class and cell subclass | 3.67e-06 | 197 | 144 | 7 | 6c57ab2efb8363828e24211c4d45e58bb73a9a4d | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 3.67e-06 | 197 | 144 | 7 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-06 | 197 | 144 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.80e-06 | 198 | 144 | 7 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-06 | 199 | 144 | 7 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-06 | 199 | 144 | 7 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-06 | 199 | 144 | 7 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-06 | 199 | 144 | 7 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.92e-06 | 199 | 144 | 7 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-06 | 200 | 144 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.06e-06 | 200 | 144 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.06e-06 | 200 | 144 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-06 | 200 | 144 | 7 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-06 | 200 | 144 | 7 | cb31cfcfa8e6d6cc610c4c22e97bc009dd8a9e7c | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-06 | 200 | 144 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-06 | 144 | 144 | 6 | cc11cce43d1af8ac63140d05faf215ae9a10cde1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 152 | 144 | 6 | 9391b46a441cf031665df1d142e3f65e98675eeb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 157 | 144 | 6 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-05 | 159 | 144 | 6 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 160 | 144 | 6 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 160 | 144 | 6 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.52e-05 | 163 | 144 | 6 | 03b2ec226adffba3ce893f3d12e549c841e662fd | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.63e-05 | 165 | 144 | 6 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-05 | 166 | 144 | 6 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-05 | 171 | 144 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Immune-mast_cell|World / Lineage, Cell type, age group and donor | 2.06e-05 | 172 | 144 | 6 | 6e8e0aac5a20dbc789bf8c6916833bb8709a411a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 175 | 144 | 6 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 175 | 144 | 6 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.35e-05 | 176 | 144 | 6 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 177 | 144 | 6 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 177 | 144 | 6 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-05 | 179 | 144 | 6 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 180 | 144 | 6 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 2.92e-05 | 183 | 144 | 6 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.01e-05 | 184 | 144 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 187 | 144 | 6 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 188 | 144 | 6 | 3638d85452de15a060146628fbbad9d2a36feb13 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 188 | 144 | 6 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.50e-05 | 189 | 144 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.60e-05 | 190 | 144 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 3.60e-05 | 190 | 144 | 6 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.60e-05 | 190 | 144 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.60e-05 | 190 | 144 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.71e-05 | 191 | 144 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|lung / Disease (COVID-19 only), tissue and cell type | 3.71e-05 | 191 | 144 | 6 | dab953682b8c9ed680a799161f837f792a7e4f33 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.71e-05 | 191 | 144 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | COVID-19-lung-Macrophage_PPARGhi_CD5Lhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.82e-05 | 192 | 144 | 6 | bcfb9c005166bc0b4f8ee2dfc0c1540e8bf0e1ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 192 | 144 | 6 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.82e-05 | 192 | 144 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.82e-05 | 192 | 144 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-05 | 192 | 144 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.82e-05 | 192 | 144 | 6 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.82e-05 | 192 | 144 | 6 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-05 | 192 | 144 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.93e-05 | 193 | 144 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 193 | 144 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 193 | 144 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 194 | 144 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 194 | 144 | 6 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 4.05e-05 | 194 | 144 | 6 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 194 | 144 | 6 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | (4)_Endothelial_cells-(4)_Lymph_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.05e-05 | 194 | 144 | 6 | 9735b86d3b2480a0b34d8aab8e7bd609d83c2454 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 4.16e-05 | 195 | 144 | 6 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 4.16e-05 | 195 | 144 | 6 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.16e-05 | 195 | 144 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-05 | 195 | 144 | 6 | d9694db6bf239636d1335016878c98f6ee2eb0eb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.16e-05 | 195 | 144 | 6 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.16e-05 | 195 | 144 | 6 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| Drug | NSC115907 | FOXRED1 TCIRG1 PTGS1 DUOX1 MTOR SLC18A2 GLS CHRDL1 DEGS2 EIF2AK3 TOP2B | 8.67e-07 | 266 | 141 | 11 | CID000005102 |
| Drug | 3-O-caffeoyl-D-quinic acid | 4.69e-06 | 40 | 141 | 5 | CID000009476 | |
| Drug | compound 31 | 6.00e-06 | 42 | 141 | 5 | CID005288687 | |
| Drug | Niflumic Acid | 6.00e-06 | 42 | 141 | 5 | ctd:D009544 | |
| Drug | sodium | CFTR SLCO4A1 SLC38A5 SLCO3A1 TCIRG1 HUWE1 PTGS1 SLC1A7 RYR2 SLC6A1 SLC5A11 MTOR SLC18A2 GLS AGTR1 KCNK2 SLC26A11 YME1L1 | 2.23e-05 | 944 | 141 | 18 | CID000000923 |
| Drug | amphimedine | 3.81e-05 | 2 | 141 | 2 | CID000100819 | |
| Drug | Dexrazoxane | 3.81e-05 | 2 | 141 | 2 | DB00380 | |
| Drug | oxoaporphine | 3.81e-05 | 2 | 141 | 2 | CID000326183 | |
| Drug | eriochrome cyanin | 3.81e-05 | 2 | 141 | 2 | CID000075762 | |
| Drug | F14512 | 3.81e-05 | 2 | 141 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 3.81e-05 | 2 | 141 | 2 | DB00694 | |
| Drug | racemosol | 3.81e-05 | 2 | 141 | 2 | CID000624971 | |
| Drug | terbium chloride | 3.81e-05 | 2 | 141 | 2 | CID000061458 | |
| Drug | radicicol | 4.00e-05 | 203 | 141 | 8 | CID000005033 | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 2.00e-05 | 12 | 135 | 3 | OBA_2045152 | |
| Disease | Massive Hepatic Necrosis | 2.08e-05 | 2 | 135 | 2 | C0001364 | |
| Disease | B cell deficiency (implicated_via_orthology) | 2.08e-05 | 2 | 135 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | lysophosphatidylcholine 20:3 measurement | 3.37e-05 | 40 | 135 | 4 | EFO_0010362 | |
| Disease | Colorectal Neoplasms | 4.32e-05 | 277 | 135 | 8 | C0009404 | |
| Disease | Colorectal Carcinoma | EYA4 CFTR ARID1A ABCA10 ABCC6 SLC1A7 FADS1 ABCA6 ABCA5 UHRF2 PIK3R5 FBXW7 | 9.64e-05 | 702 | 135 | 12 | C0009402 |
| Disease | Adenoid Cystic Carcinoma | 9.89e-05 | 100 | 135 | 5 | C0010606 | |
| Disease | triglycerides in large VLDL measurement | 1.28e-04 | 56 | 135 | 4 | EFO_0022178 | |
| Disease | triglycerides in VLDL measurement | 1.57e-04 | 59 | 135 | 4 | EFO_0022326 | |
| Disease | cholesteryl ester measurement | 1.88e-04 | 257 | 135 | 7 | EFO_0010351 | |
| Disease | total lipids in very large VLDL measurement | 1.90e-04 | 62 | 135 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.90e-04 | 62 | 135 | 4 | EFO_0022299 | |
| Disease | cholesterol in very large VLDL measurement | 2.29e-04 | 65 | 135 | 4 | EFO_0022230 | |
| Disease | acute lymphoblastic leukemia | 2.42e-04 | 66 | 135 | 4 | EFO_0000220 | |
| Disease | total lipids in large VLDL | 2.57e-04 | 67 | 135 | 4 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 2.72e-04 | 68 | 135 | 4 | EFO_0022265 | |
| Disease | 1-stearoyl-GPC (18:0) measurement | 3.08e-04 | 6 | 135 | 2 | EFO_0800217 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement | 3.08e-04 | 6 | 135 | 2 | EFO_0800434 | |
| Disease | 1-arachidonoyl-GPI (20:4) measurement | 4.30e-04 | 7 | 135 | 2 | EFO_0800256 | |
| Disease | 1-linoleoyl-GPI (18:2) measurement | 4.30e-04 | 7 | 135 | 2 | EFO_0800266 | |
| Disease | 1-palmitoyl-GPE (16:0) measurement | 4.30e-04 | 7 | 135 | 2 | EFO_0800245 | |
| Disease | stromal cell-derived factor 1 measurement | 4.30e-04 | 7 | 135 | 2 | EFO_0020756 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPI (16:0/18:2) measurement | 4.30e-04 | 7 | 135 | 2 | EFO_0800609 | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 5.71e-04 | 8 | 135 | 2 | OBA_2045153 | |
| Disease | phospholipids:total lipids ratio | 6.39e-04 | 227 | 135 | 6 | EFO_0020946 | |
| Disease | renovascular hypertension (implicated_via_orthology) | 7.32e-04 | 9 | 135 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | longitudinal alcohol consumption measurement | 7.32e-04 | 9 | 135 | 2 | EFO_0007645 | |
| Disease | 1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement | 7.32e-04 | 9 | 135 | 2 | EFO_0800439 | |
| Disease | 1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4) measurement | 7.32e-04 | 9 | 135 | 2 | EFO_0800412 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [1] measurement | 9.13e-04 | 10 | 135 | 2 | EFO_0800507 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 9.13e-04 | 10 | 135 | 2 | EFO_0800469 | |
| Disease | concentration of large LDL particles measurement | 1.08e-03 | 44 | 135 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 1.08e-03 | 44 | 135 | 3 | EFO_0022225 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.11e-03 | 11 | 135 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | middle temporal gyrus volume measurement | 1.11e-03 | 11 | 135 | 2 | EFO_0010316 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.29e-03 | 260 | 135 | 6 | EFO_0008317 | |
| Disease | free cholesterol in small VLDL measurement | 1.31e-03 | 47 | 135 | 3 | EFO_0022272 | |
| Disease | free cholesterol in medium VLDL measurement | 1.31e-03 | 47 | 135 | 3 | EFO_0022269 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.33e-03 | 12 | 135 | 2 | EFO_0800500 | |
| Disease | phosphatidylcholine 34:4 measurement | 1.33e-03 | 12 | 135 | 2 | EFO_0010378 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 1.33e-03 | 12 | 135 | 2 | EFO_0800453 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.33e-03 | 12 | 135 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | glycerophospholipid measurement | 1.48e-03 | 49 | 135 | 3 | EFO_0007630 | |
| Disease | phosphatidylcholine 40:7 measurement | 1.57e-03 | 13 | 135 | 2 | EFO_0021477 | |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 1.57e-03 | 13 | 135 | 2 | EFO_0800413 | |
| Disease | phospholipids in very small VLDL measurement | 1.66e-03 | 51 | 135 | 3 | EFO_0022300 | |
| Disease | phospholipids in IDL measurement | 1.76e-03 | 52 | 135 | 3 | EFO_0022164 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0022085 | |
| Disease | diacylglycerol 38:4 measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0020066 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.86e-03 | 53 | 135 | 3 | C1961099 | |
| Disease | cholesterol in small VLDL measurement | 1.86e-03 | 53 | 135 | 3 | EFO_0022228 | |
| Disease | triglycerides in medium VLDL measurement | 2.07e-03 | 55 | 135 | 3 | EFO_0022155 | |
| Disease | health study participation | 2.07e-03 | 195 | 135 | 5 | EFO_0010130 | |
| Disease | liver volume | 2.10e-03 | 15 | 135 | 2 | EFO_0600048 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 2.10e-03 | 15 | 135 | 2 | EFO_0800508 | |
| Disease | glycerate measurement | 2.10e-03 | 15 | 135 | 2 | EFO_0021029 | |
| Disease | phosphatidate measurement | 2.10e-03 | 15 | 135 | 2 | EFO_0020047 | |
| Disease | triglycerides in very large VLDL measurement | 2.17e-03 | 56 | 135 | 3 | EFO_0022325 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.17e-03 | 56 | 135 | 3 | EFO_0022279 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.29e-03 | 57 | 135 | 3 | EFO_0022284 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0800184 | |
| Disease | amygdala volume change measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0021490 | |
| Disease | cholesterol in IDL measurement | 2.40e-03 | 58 | 135 | 3 | EFO_0021899 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.53e-03 | 59 | 135 | 3 | EFO_0022337 | |
| Disease | phospholipids in small VLDL measurement | 2.65e-03 | 60 | 135 | 3 | EFO_0022146 | |
| Disease | total lipids in VLDL measurement | 2.65e-03 | 60 | 135 | 3 | EFO_0022314 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.65e-03 | 60 | 135 | 3 | EFO_0022233 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.77e-03 | 303 | 135 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | free cholesterol in IDL measurement | 2.78e-03 | 61 | 135 | 3 | EFO_0022181 | |
| Disease | free cholesterol in very large VLDL measurement | 2.78e-03 | 61 | 135 | 3 | EFO_0022274 | |
| Disease | phospholipids in large VLDL measurement | 2.91e-03 | 62 | 135 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 2.91e-03 | 62 | 135 | 3 | EFO_0022322 | |
| Disease | phosphatidylcholine 36:4 measurement | 3.03e-03 | 18 | 135 | 2 | EFO_0010382 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 3.03e-03 | 18 | 135 | 2 | OBA_2045155 | |
| Disease | triglycerides to total lipids in IDL percentage | 3.04e-03 | 63 | 135 | 3 | EFO_0022329 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.04e-03 | 63 | 135 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.04e-03 | 63 | 135 | 3 | EFO_0022239 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.16e-03 | 215 | 135 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | very low density lipoprotein particle size measurement | 3.31e-03 | 133 | 135 | 4 | EFO_0008594 | |
| Disease | cholesterol in large VLDL measurement | 3.33e-03 | 65 | 135 | 3 | EFO_0021902 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 3.38e-03 | 19 | 135 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | diacylglycerol 38:5 measurement | 3.38e-03 | 19 | 135 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 3.38e-03 | 19 | 135 | 2 | EFO_0020065 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.49e-03 | 220 | 135 | 5 | EFO_0004529, EFO_0008317 | |
| Disease | viral load | 3.59e-03 | 136 | 135 | 4 | EFO_0010125 | |
| Disease | hearing loss | 3.62e-03 | 67 | 135 | 3 | EFO_0004238 | |
| Disease | radiation-induced disorder | 3.62e-03 | 67 | 135 | 3 | EFO_0009565 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 3.62e-03 | 67 | 135 | 3 | EFO_0022245 | |
| Disease | corneal hysteresis | 3.74e-03 | 20 | 135 | 2 | EFO_0010066 | |
| Disease | Severe Combined Immunodeficiency | 3.74e-03 | 20 | 135 | 2 | C0085110 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 3.76e-03 | 224 | 135 | 5 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.76e-03 | 224 | 135 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | triglycerides to phosphoglycerides ratio | 3.78e-03 | 68 | 135 | 3 | EFO_0022327 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 3.83e-03 | 225 | 135 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 3.94e-03 | 69 | 135 | 3 | EFO_0022341 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 4.12e-03 | 21 | 135 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 4.12e-03 | 21 | 135 | 2 | OBA_2045076 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.13e-03 | 229 | 135 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 4.27e-03 | 71 | 135 | 3 | EFO_0022259 | |
| Disease | triglycerides to total lipids in small HDL percentage | 4.44e-03 | 72 | 135 | 3 | EFO_0022336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYPLLGCLISFIKIS | 1176 | Q8WWZ7 | |
| LLLIFISIAGILYKF | 46 | Q7L211 | |
| KVFLPVFYSLIFVLG | 46 | O00590 | |
| FIPGFIGSLKQLTYL | 221 | Q96RT1 | |
| LLVKFFPLLLLYPLT | 106 | Q7Z695 | |
| FVVFLSVLPYALIKG | 316 | P13569 | |
| DIFSLGLILFELLYP | 1006 | Q9NZJ5 | |
| ALVDIPLYFLILFSI | 981 | Q8WWZ4 | |
| TFGAFYIPLALILIL | 186 | P30939 | |
| GTLKLYFRELPEPLF | 1126 | P11274 | |
| ILGFLFPFLIILTSY | 201 | P30556 | |
| KIFVLGPKYSPLEFL | 521 | Q7Z2Z2 | |
| LLLALYFDKILPYGD | 411 | Q8N139 | |
| LVPSYTLLGFKTFLE | 1161 | Q8N139 | |
| PFFIKELIVGLSIYT | 306 | P28566 | |
| PLFTYGLIKLAFLSS | 21 | A6NHX0 | |
| VYPVFAKLSLLGLAA | 181 | Q96IZ2 | |
| FLYAEIGLILIFCLP | 11 | Q9UHQ4 | |
| PLLATEFRGLALKYL | 491 | Q9H816 | |
| LFIPVASLLLDVVYK | 1056 | Q9Y2Q0 | |
| YDILLPLFRLLAKVG | 71 | Q96MI9 | |
| PVLEKILFGVFLAIY | 21 | Q6IEU7 | |
| YFTRIIAFLLKLAVP | 506 | Q5VW38 | |
| IKQGLLPSLEDLLFY | 131 | O94925 | |
| FLIQVLFYLLPIGKV | 266 | Q14739 | |
| LLGFTDYPKLQIPLF | 16 | Q8NGL3 | |
| DYPKLQIPLFLVFLL | 21 | Q8NGL3 | |
| AELQLPLFLLFLGIY | 21 | Q8WZ84 | |
| LSQLPGLLELLVEYF | 1706 | O14497 | |
| RGIGYLKLICFLIPF | 311 | Q7Z5J8 | |
| IFFLVPAIIYGGDKL | 1251 | Q9NRD9 | |
| PKLEIPLFLVFLSFY | 21 | Q8NGQ6 | |
| PLFLVFLSFYLVTLL | 26 | Q8NGQ6 | |
| PELHILLFLLFLFVY | 46 | Q8NGE7 | |
| SELQLPLFLVFLGIY | 56 | Q8NG78 | |
| GNKFGVLLFLYSVLL | 176 | Q9H8M7 | |
| LDAPLFGIFLVVYVL | 21 | Q8NGN6 | |
| LLSYAFIVAAILKIP | 216 | Q8NGA6 | |
| LLSYAFIVADILKIP | 216 | O60403 | |
| EFILLGLSGYPKLEI | 11 | Q8NGS5 | |
| GLSGYPKLEIIFFAL | 16 | Q8NGS5 | |
| LLIIPFTFLTKLLPY | 156 | Q8NGI2 | |
| GVLLPKLVLLFVYAD | 11 | Q96J86 | |
| VFYALLGIPLNVIFL | 126 | Q96T55 | |
| KIFCIIYALLGIPLF | 171 | O95069 | |
| LSVFIPPYFAEKIIL | 336 | Q8NDZ0 | |
| SLVAFLGYLLLLKGF | 801 | Q9H6A9 | |
| LDPLLIFFSYGLIGK | 216 | Q8NGJ8 | |
| SIIPALKRLSLGLFY | 226 | Q6P1A2 | |
| LTELPKDSFEGLLYL | 591 | Q96QE4 | |
| PPYLKLVISFLFISA | 281 | A6NFX1 | |
| LDAPLFGVFLVVYVL | 21 | Q8NGN5 | |
| YLASFVFVVLPLGLI | 201 | Q8N628 | |
| HKFFPYILLLFAILL | 106 | Q96RD7 | |
| LSGYFLQLKFDPELL | 351 | P23219 | |
| LIYLKITGLLFPTSD | 546 | P78316 | |
| FLEGFYEIIPKRLIS | 4226 | Q7Z6Z7 | |
| IKIALEISLPGSFIY | 126 | Q96RW7 | |
| LFILFPFLLILGSYV | 206 | Q9H209 | |
| PLDVNYLLFLIILGK | 21 | Q9UJ42 | |
| PYIKLITGFLFTSLA | 306 | Q8NA29 | |
| LAKVLLYSLGGAFPI | 556 | O95677 | |
| LLGLAFLEYFPVELI | 476 | Q7L8L6 | |
| LPLLSVKFLTRLYEA | 226 | Q9NXS3 | |
| AKIAQLYLPFVGLLL | 1161 | Q5JSL3 | |
| ILPLLYFFITKKNPI | 311 | O00341 | |
| KYIFSLLFFLLLEGG | 11 | Q9BU40 | |
| QLPLKRELFGFKSYL | 401 | Q5T9S5 | |
| YGLVFLLVPALALFL | 51 | Q5R3K3 | |
| LLDPKLCYLLDGILF | 26 | P20963 | |
| ISLLPKELALYVLSF | 281 | Q969H0 | |
| LSPFLFTRFYLGEKI | 466 | Q96CU9 | |
| LKPVVYLLASSFLGL | 206 | Q6QHC5 | |
| FFLTYVPLLGLKAFL | 306 | O60427 | |
| LPLEILKYIAGFLDS | 576 | Q9UH90 | |
| YFLTLLGKHELVPVL | 76 | Q9BSK0 | |
| LVIKPYLALEGSVAF | 21 | Q16048 | |
| LVIKPYLALEGSVAF | 21 | Q9BQD1 | |
| ALLFLLRCYFVLEPK | 631 | Q8IXH8 | |
| KYLRFLLGLPVGSTF | 6621 | Q8NDH2 | |
| FLKLLPLELSFYLLK | 56 | Q9UKT8 | |
| ALYSLPRAFFKVPLL | 526 | Q8NFJ9 | |
| LFGAVELPSKLLVYL | 381 | Q9Y694 | |
| FLFVPLIKLFYTLLI | 1816 | Q92736 | |
| GILLFLFTLKCVYLP | 2616 | Q8TDX9 | |
| LFLYSVPGYLVKKIL | 1981 | Q9HC10 | |
| LDAPLFGIFLVVYVL | 21 | Q8NGN4 | |
| LLSYAFIVAAILKIP | 216 | Q9Y4A9 | |
| EFLLLGLSGYPKIEI | 41 | Q8NGS6 | |
| VILAPFFNPIIYSLK | 306 | Q8NGW6 | |
| VALGGEFKLYLPQLI | 1061 | P42345 | |
| EIPILIIEGFLLFNY | 91 | Q9NWW6 | |
| IIEGFLLFNYKPLDT | 96 | Q9NWW6 | |
| YIGSFLARAKFIPLI | 406 | Q9NYV6 | |
| YFLTLIFAGVPLFLL | 86 | P30531 | |
| VTFVPGLYKIFDEIL | 96 | Q02880 | |
| SPELKSYALGVLFLL | 566 | Q9UIG8 | |
| FTVPKLLSLFLEFIG | 326 | O95255 | |
| SYLFIIKSELPLVIG | 141 | Q8WUX1 | |
| IAKFSLLVGLIFGYL | 231 | A1A5C7 | |
| ALSLYLFKLGIAPQI | 151 | Q13576 | |
| PVLEKILFGVFLAIY | 21 | Q8NGP8 | |
| EVILTLFGFKLLYPD | 281 | P53041 | |
| PLETLALTYGFLEKV | 296 | A3QJZ6 | |
| LIYILFFLGDPVKEC | 211 | Q7Z3Q1 | |
| LIFIFPGLFYLKLSR | 406 | Q8IZM9 | |
| PGDIAVLVLYFLFVL | 26 | Q8WWX8 | |
| TLVFALGLFFLLLPY | 31 | P0DKV0 | |
| TGLYPELFTLLLKLV | 1156 | Q7Z745 | |
| FILLPGVTEFYLLAA | 101 | A6NF89 | |
| LALSVGIFPYVLKLL | 466 | Q8N122 | |
| GLLYKVLGVLFFAIA | 671 | Q96BD0 | |
| LLLIYSEKIPSVLFL | 391 | Q8IW75 | |
| GILIAIDALSFYLPL | 241 | Q70Z44 | |
| VLSLIPTDLLYFKLG | 246 | P29973 | |
| ILQTLLDLFFPGYSK | 786 | Q96PU4 | |
| LLLLERFLPHYFKGV | 291 | Q9Y2C2 | |
| FSLGLAIFKPDLITY | 41 | A8MUV8 | |
| LPFLKNTVILLYPFA | 216 | Q53HI1 | |
| IPDEYLLSLKFLFGS | 26 | Q19AV6 | |
| GLTFLLAPFTKFLID | 156 | O15374 | |
| EKGTYDLLTPLALLF | 71 | Q8WYR1 | |
| RLGFLLDFISYPVIK | 141 | Q86WA9 | |
| FGELLAELLKIPFVY | 156 | P06133 | |
| GPKDLVTILFYIFIT | 71 | Q15035 | |
| LLPLLNTVKFLLLFY | 551 | Q7Z404 | |
| ITALPLYFEGFLLIK | 21 | Q9ULZ2 | |
| YFLLFGGDLLLKPIK | 1326 | Q9H5I5 | |
| LPVLGVLFLLYCFTK | 476 | Q9C0B7 | |
| VLELPYLGSAVSLFL | 246 | A8MV23 | |
| QLFPELLFLGTAKLY | 116 | O94813 | |
| LLIQGSPEKYILFLI | 71 | Q7L804 | |
| KFKYAVLFLLGLFVL | 161 | P67812 | |
| PLPLNKTLFLGYAFL | 1721 | Q12888 | |
| LLVPGLIKDVLYEFR | 681 | Q9P2J2 | |
| KSIELFYKFVPLLPG | 1186 | P78527 | |
| LLFGIYGLLKNPFLS | 301 | Q96TA2 | |
| TFVPGLYKIFDEILV | 76 | P11388 | |
| FLGIALSKPDLITYL | 51 | Q05481 | |
| PADLALVIYLILAGF | 216 | Q9BZW4 | |
| LKFFLSLYGHKLPVI | 581 | Q9UNX4 | |
| VLYEFVGKTAPFLVL | 241 | Q05940 | |
| IPYKAIALATVLFLI | 41 | Q96A57 | |
| LLELFIFLYKGVLLP | 36 | Q9P0N5 | |
| WGYKILFLDVLFPLV | 1336 | Q9NYU2 | |
| LPELTFLLGLFGYLV | 571 | Q13488 | |
| IGYFLFLFALPILVA | 561 | O76024 | |
| CIILKGLFEVLDLYP | 641 | Q96L42 | |
| SILVAINPFKFLPIY | 181 | Q13459 |